Literature DB >> 20695931

Combination antihypertensive treatment: is initiation order important?

John G Gums, Julie A Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20695931      PMCID： PMC8816468          DOI： 10.1111/j.1751-7176.2010.00319.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  6 in total

1.  Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.

Authors:  Karen Sliwa; Gavin R Norton; Ngalulawa Kone; Geoffrey Candy; John Kachope; Angela J Woodiwiss; Carlos Libhaber; Pinhas Sareli; Rafique Essop
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

2.  Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order.

Authors:  J A Johnson; Y Gong; K R Bailey; R M Cooper-DeHoff; A B Chapman; S T Turner; G L Schwartz; K Campbell; S Schmidt; A L Beitelshees; E Boerwinkle; J G Gums
Journal:  Clin Pharmacol Ther       Date:  2009-07-01       Impact factor: 6.875

3.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

4.  Comparative evaluation of enalapril and hydrochlorothiazide in elderly patients with mild to moderate hypertension.

Authors:  J G Gums; L M Lopez; G P Quay; G H Stein; D L McCarley
Journal:  Drug Intell Clin Pharm       Date:  1988-09

5.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.

Authors:  M R Law; N J Wald; J K Morris; R E Jordan
Journal:  BMJ       Date:  2003-06-28

6.  Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.

Authors:  Julie A Johnson; Eric Boerwinkle; Issam Zineh; Arlene B Chapman; Kent Bailey; Rhonda M Cooper-DeHoff; John Gums; R Whit Curry; Yan Gong; Amber L Beitelshees; Gary Schwartz; Stephen T Turner
Journal:  Am Heart J       Date:  2009-03       Impact factor: 4.749
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.